Product category: Surgical instruments and products
Synthetic surgical glue Glubran 2 is a medical device Class III CE marked for internal and external use.
Glubran 2 is a synthetic biodegradable(1) cyanoacrylate basis glue, modified by the addition of a monomer synthesized by the manufacturer GEM.
Glubran 2 is ready for use(2-5). It has high adhesive(6) and haemostatic(7) properties and once it is polymerised it creates an efficient antiseptic barrier(1,8,9) against the most diffused infective or pathogenic agents during the surgical intervention.
Glubran 2 polymerises quickly in contact with live tissue and wet environment creating a thin and elastic film having high tensile properties which guarantee strong adhesion to the tissues(6). This film naturally conforms with the tissues on which it was applied; it is not permeable to liquids and is not altered by blood or organic liquids(7,10).
INDICATIONS OF USE
Glubran 2 is a glue which is used in open and laparoscopic surgery(2-5,7,8,10-64) and in digestive tract endoscopy(42,45,46,65-77).
Furthermore Glubran 2 is used as embolising agent in radiology and vascular neuroradiology(78-97).
GEM is an Italian manufacturer and distributor of medical devices. It was founded in 1994 with a business culture primarily based on research, development, production and marketing of innovative medical devices.
In 1995 GEM commercializes the Glubran glue, to be used in surgical procedures.
Soon after, GEM manufactured the second generation of the product Glubran 2 with a new formula that allows its use even in endovascular procedures.
In 1998 both products obtained the CE certification for internal use.
Currently GEM manufactures the Glubran 2 glue awarded by users for its variety and diversity of use.
In these eleven years GEM has designed and manufactured many application devices for the glue in order to facilitate and enhance its use.
In 2007 Glubran Tiss, surgical glue for skin applications, entered the market. At present Glubran 2, Glubran Tiss and their application devices are sold in over 40 countries worldwide.
Our work is based on the continuous research and its aim is to develop innovative surgical medical devices, in order to anticipate the demands of an increasingly sophisticated market.